The Perils of Pull-Through

Listen on: Apple Podcasts or Spotify
In this episode of the IDI Podcast, Jack Timko, Senior Principal, Valuate Health Consultancy, discusses the perils of pull-through in market access and shares how data may be the answer.
Listen on: Apple Podcasts or Spotify
Archbow Consulting, Entrée Health, and Valuate Health Consultancy are sister companies under the Value and Access division of Omnicom Health Group. Learn more about our united organizations here.
For additional insights on this topic, you may also enjoy the following:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
DTC/DTP + Telemedicine – The Next Big Thing in Pharma?
The May 2025 Executive Order marks a seismic shift in the U.S. pharmaceutical patient access market.
Evolving Pharma: How DTC/DTP and Telemedicine are Redefining the Industry’s Future
By understanding DTC, DTP and the intersection with telemedicine, pharma can deliver more value to patients and drive measurable results.
Significant Changes in Healthcare: Regulations in Law
The pharmaceutical industry is facing a wave of regulatory changes in 2025 that will have a significant impact on stakeholders.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|


